EVP, General Counsel
Tue, Mar 4, 2025
Mar 4
2,572 shares @ $8.99
Decreased holdings by -2.20%
Net across this filing: +50.20% (+37,428 shares)
7th largest trade (out of 23)
Positive 90D History
Trade made by an officer
Net holdings across this filing: +50.2% (+37,428 shares)
100% win rate · +25.9% median edge vs SPY (5 trades, 90-day · small sample)
Price 50% below 200-day moving average
Small Cap stock — insider trades carry more weight
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
NTLAIntellia Therapeutics, Inc.
Health CareDiagnostics & Research
1D0.00%
1W+6.20%
1M+19.66%
3M+1.82%
6M—
1Y—